106 related articles for article (PubMed ID: 2617471)
1. Fibrinogen Baltimore IV: congenital dysfibrinogenemia with a gamma 275 (Arg----Cys) substitution.
Schmelzer CH; Ebert RF; Bell WR
Thromb Res; 1989 Oct; 56(2):307-16. PubMed ID: 2617471
[TBL] [Abstract][Full Text] [Related]
2. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys).
Borrell M; Garí M; Coll I; Vallvé C; Tirado I; Soria JM; Sala N; Muñoz C; Oliver A; García A
Blood Coagul Fibrinolysis; 1995 May; 6(3):198-206. PubMed ID: 7654933
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly----Val (GGC----GTC) mutation.
Bantia S; Mane SM; Bell WR; Dang CV
Blood; 1990 Dec; 76(11):2279-83. PubMed ID: 2257302
[TBL] [Abstract][Full Text] [Related]
4. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
[TBL] [Abstract][Full Text] [Related]
6. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
[TBL] [Abstract][Full Text] [Related]
8. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.
Koopman J; Haverkate F; Grimbergen J; Lord ST; Mosesson MW; DiOrio JP; Siebenlist KS; Legrand C; Soria J; Soria C
J Clin Invest; 1993 Apr; 91(4):1637-43. PubMed ID: 8473507
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Matsumoto II: gamma 308 Asn-->Lys (AAT-->AAG) mutation associated with bleeding tendency.
Okumura N; Furihata K; Terasawa F; Ishikawa S; Ueno I; Katsuyama T
Br J Haematol; 1996 Sep; 94(3):526-8. PubMed ID: 8790154
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
Loreth RM; Meyer M; Albert FW
Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Baltimore IV: congenital dysfibrinogenemia with delayed fibrin monomer polymerization.
Ebert RF; Bell WR
Thromb Res; 1985 Apr; 38(2):121-8. PubMed ID: 4002201
[TBL] [Abstract][Full Text] [Related]
13. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
[TBL] [Abstract][Full Text] [Related]
14. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
Brown CH; Crowe MF
J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
[TBL] [Abstract][Full Text] [Related]
15. Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308----Ile mutation.
Bantia S; Bell WR; Dang CV
Blood; 1990 Apr; 75(8):1659-63. PubMed ID: 2328317
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Logroño. A new case of congenital dysfibrinogenemia.
Rocha E; Lasierra J; Narvaiza MJ; Vilades E; Palacios E; Fernandez J
Ric Clin Lab; 1984; 14(4):663-72. PubMed ID: 6522973
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
[TBL] [Abstract][Full Text] [Related]
18. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
Furlan M; Leupin L; Biasiutti FD; Lämmle B
Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
